JULIE ROUDYBUSH: Open Payments
NPI 1750091930 · MCKEESPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,876 in 90 payments from 19 companies in 2025. Trend: 2023 $128 · 2024 $2,318 · 2025 $2,876
Food & beverage: $2,876
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $640 |
| Madrigal Pharmaceuticals | 5 | $461 |
| AstraZeneca Pharmaceuticals LP | 9 | $335 |
| Axsome Therapeutics, Inc. | 12 | $301 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $239 |
| PFIZER INC. | 7 | $197 |
| ABBVIE INC. | 8 | $145 |
| Amgen Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $113 |
| Lilly USA, LLC | 5 | $104 |
Products named: REZDIFFRA, Ozempic, Auvelity, Wegovy, BREZTRI, CAPLYTA, NURTEC ODT, REPATHA.
Industry payments across PA — which companies pay providers there.
